Swedish patients’ trust in the bioequivalence of interchangeable generics. What factors are important for low trust?

BACKGROUND: Generic substitution (GS), is a cost-containment strategy meant to contain pharmaceutical expenditure without compromising health objectives. In order to shape GS into a policy that is both efficient and safe it is crucial to understand which factors are most important for patients’ trus...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsson, Erika, Svensberg, Karin, Wallach-Kildemoes, Helle, Carlsson, Emma, Hällkvist, Caroline, Kaae, Susanne, Sporrong, Sofia Kälvemark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322990/
https://www.ncbi.nlm.nih.gov/pubmed/30637031
http://dx.doi.org/10.18549/PharmPract.2018.04.1298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322990/
https://www.ncbi.nlm.nih.gov/pubmed/30637031
http://dx.doi.org/10.18549/PharmPract.2018.04.1298

Ejemplares similares